Bachem AG and GlyTech, Inc. announce co-promotion agreement Montag, 06. Oktober 2014 - 20:24

Bachem the leading peptide manufacturer, and GlyTech Inc. (Kyoto, Japan), the world-leading developer of glycosylated drugs, announced today that they have entered into a co-promotion agreement for GlyTech's glycosylation technology.